1. Combination Treatment of Renal Cell Carcinoma with Belinostat and 5-Fluorouracil: A Role for Oxidative Stress Induced DNA Damage and HSP90 Regulated Thymidine Synthase
   Mi Joung Kim et al, 2015, Journal of Urology CrossRef
2. The Synergistic In Vitro and In Vivo Antitumor Effect of Combination Therapy with Salinomycin and 5-Fluorouracil against Hepatocellular Carcinoma
   Fan Wang et al, 2014, PLoS ONE CrossRef
3. Eg5 inhibitor, a novel potent targeted therapy, induces cell apoptosis in renal cell carcinoma
   Sentai Ding et al, 2014, Tumor Biology CrossRef
4. Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers
   Uddin MD. Nazim et al, 2017, Oncotarget CrossRef
5. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells
   YUKIE YOSHII et al, 2016, International Journal of Oncology CrossRef
6. Establishment of a ccRCC patient-derived chick chorioallantoic membrane model for drug testing
   Martine Charbonneau et al, 2022, Frontiers in Medicine CrossRef
7. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model
   M. Denorme et al, 2014, Cancer Letters CrossRef
8. Molecular analysis of sunitinib resistant renal cell carcinoma cells after sequential treatment with RAD001 (everolimus) or sorafenib
   Eva Juengel et al, 2015, Journal of Cellular and Molecular Medicine CrossRef
9. Renal cell carcinoma escapes death by p53 depletion through transglutaminase 2-chaperoned autophagy
   J H Kang et al, 2016, Cell Death & Disease CrossRef
10. In vitro and in vivo targeting of bladder carcinoma with metformin in combination with cisplatin
    DONG WANG et al, 2015, Oncology Letters CrossRef
11. Differential regulation of sunitinib targets predicts its tumor-type-specific effect on endothelial and/or tumor cell apoptosis
    Guilhem Bousquet et al, 2013, Cancer Chemotherapy and Pharmacology CrossRef
12. The anti-angiogenic tyrosine kinase inhibitor Pazopanib kills cancer cells and disrupts endothelial networks in biomimetic three-dimensional renal tumouroids
    Katerina Stamati et al, 2020, Journal of Tissue Engineering CrossRef
13. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder
    Makito Miyake et al, 2017, Oncotarget CrossRef
14. Unlocking the therapeutic potential of drug combinations through synergy prediction using graph transformer networks
    Waleed Alam et al, 2024, Computers in Biology and Medicine CrossRef
15. Autophagy Inhibition Promotes 5-Fluorouraci-Induced Apoptosis by Stimulating ROS Formation in Human Non-Small Cell Lung Cancer A549 Cells
    Xiaohong Pan et al, 2013, PLoS ONE CrossRef
16. Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma
    Lifen Deng et al, 2013, BMC Cancer CrossRef
17. Oncolytic peptide nanomachine circumvents chemo resistance of renal cell carcinoma
    Jia Yang et al, 2022, Biomaterials CrossRef
18. Antitumor Effects of Cannabinoids in Human Pancreatic Ductal Adenocarcinoma Cell Line (Capan-2)-Derived Xenograft Mouse Model
    Siriwan Sakarin et al, 2022, Frontiers in Veterinary Science CrossRef
19. Hispidulin Potentiates the Antitumor Effect of Sunitinib Against Human Renal Cell Carcinoma in Laboratory Models
    Hui Gao et al, 2015, Cell Biochemistry and Biophysics CrossRef
20. Targeting Renal Cell Carcinoma with Gambogic Acid in Combination with Sunitinib in Vitro and in Vivo
    Xiao-Liang Jiang et al, 2012, Asian Pacific Journal of Cancer Prevention CrossRef
21. Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy
    E. Diamond et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
22. Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma
    Shuhei Kamada et al, 2021, Oncogene CrossRef
23. The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study
    Makito Miyake et al, 2016, BMC Research Notes CrossRef